A new analysis from Copenhagen Economics highlights how parallel imports contribute to a more resilient medicine supply while generating significant savings for Danish society. In 2025 alone, parallel imports saved Denmark DKK 665 million.

As medicine shortages and supply chain vulnerabilities continue to challenge healthcare systems across Europe, ensuring reliable access to affordable medicine has become an increasingly important priority.

A new report by Copenhagen Economics, commissioned by the Danish Association for Parallel Importers of Medicines (FPM), demonstrates the important role of parallel imports in addressing both challenges.

“A reliable supply of medicine is essential for patients and healthcare systems. By sourcing medicines across Europe, we help reduce dependence on individual supply routes and make the supply of medicine more flexible and resilient. This is just as important as the significant savings we generate. Ultimately, it’s about ensuring that more patients have access to the medicine they need,” says Flemming Wagner, CEO of Abacus Medicine Group.


Significant savings for Danish society

According to the analysis, parallel imports generated DKK 665 million in savings for Danish society in 2025, corresponding to approximately 2% of total Danish medicine expenditure.
Of these savings, DKK 234 million came directly from lower-priced parallel-imported medicines, while an additional DKK 431 million resulted from increased competition, encouraging original manufacturers to offer lower prices.

Parallel imports currently account for approximately 25% of the Danish pharmacy market, illustrating their significant contribution to competition and affordability.

“Europe is rightly focusing on how to make medicine supply chains more resilient. The discussion is often focused on production and stockpiling, but creating a robust supply network is also important. Here, parallel importers play a central role in securing the supply of medicine to patients,” says Ida Sofie Jensen, Director of the Danish Association for Parallel Importers of Medicines (FPM).


Strengthening Europe’s medicine supply

By sourcing medicines from multiple countries and suppliers, parallel importers help diversify supply chains and reduce dependence on individual supply routes. This creates greater flexibility when shortages or disruptions occur, while increased competition helps keep medicine prices down.

The findings come at a time when medicine security is high on the European political agenda, with initiatives such as the EU’s Critical Medicines Act highlighting the need for more resilient supply chains.

For Abacus Medicine Group, the findings reinforce the importance of parallel imports in improving access to medicine – both physically and financially – while helping healthcare systems make better use of their resources.

Read the report from Copenhagen Economics